Welcome to LookChem.com Sign In|Join Free

CAS

  • or

20103-08-6

Post Buying Request

20103-08-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

20103-08-6 Usage

Derived from

naphthalene

Usage

synthetic intermediate in research and industry

Physical form

white to off-white solid at room temperature

Molecular weight

205.26 g/mol

Potential applications

organic synthesis, pharmaceuticals

Unique features

chemical structure and properties

Utilization

building block for the synthesis of various organic compounds and pharmaceutical products

Versatility

potential applications in various fields of chemistry and industry

Check Digit Verification of cas no

The CAS Registry Mumber 20103-08-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,0,1,0 and 3 respectively; the second part has 2 digits, 0 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 20103-08:
(7*2)+(6*0)+(5*1)+(4*0)+(3*3)+(2*0)+(1*8)=36
36 % 10 = 6
So 20103-08-6 is a valid CAS Registry Number.

20103-08-6Downstream Products

20103-08-6Relevant articles and documents

Discovery of phosphoinositide 3-kinases (PI3K) p110β isoform inhibitor 4-[2-hydroxyethyl(1-naphthylmethyl)amino]-6-[(2S)-2-methylmorpholin-4-yl]-1H- pyrimidin-2-one, an effective antithrombotic agent without associated bleeding and insulin resistance

Giordanetto, Fabrizio,Wallberg, Andreas,Ghosal, Saswati,Iliefski, Tommy,Cassel, Johan,Yuan, Zhong-Qing,Von Wachenfeldt, Henrik,Andersen, Soren M.,Inghardt, Tord,Tunek, Anders,Nylander, Sven

supporting information, p. 6671 - 6676,6 (2012/12/12)

Structure-based evolution of the original fragment leads resulted in the identification of 4-[2-hydroxyethyl(1-naphthylmethyl)amino]-6-[(2S)-2- methylmorpholin-4-yl]-1H-pyrimidin-2-one, (S)-21, a potent, selective phosphoinositide 3-kinases (PI3K) p110β isoform inhibitor with favourable in vivo antiplatelet effect. Despite its antiplatelet action, (S)-21 did not significantly increase bleeding time in dogs. Additionally, due to its enhanced selectivity over p110α, (S)-21 did not induce any insulin resistance in rats.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 20103-08-6